| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69339-169-03 | 69339-169 | HUMAN PRESCRIPTION DRUG | Teriflunomide | Teriflunomide | TABLET | ORAL | 20240102 | N/A | ANDA | ANDA209555 | Natco Pharma USA LLC | TERIFLUNOMIDE | 7 mg/1 | 30 TABLET in 1 BOTTLE (69339-169-03) |
| 69339-169-09 | 69339-169 | HUMAN PRESCRIPTION DRUG | Teriflunomide | Teriflunomide | TABLET | ORAL | 20240102 | N/A | ANDA | ANDA209555 | Natco Pharma USA LLC | TERIFLUNOMIDE | 7 mg/1 | 90 TABLET in 1 BOTTLE (69339-169-09) |
| 69339-169-93 | 69339-169 | HUMAN PRESCRIPTION DRUG | Teriflunomide | Teriflunomide | TABLET | ORAL | 20230617 | N/A | ANDA | ANDA209555 | Natco Pharma USA LLC | TERIFLUNOMIDE | 7 mg/1 | 2 BLISTER PACK in 1 CARTON (69339-169-93) / 30 TABLET in 1 BLISTER PACK |
| 69339-170-03 | 69339-170 | HUMAN PRESCRIPTION DRUG | Teriflunomide | Teriflunomide | TABLET | ORAL | 20240102 | N/A | ANDA | ANDA209555 | Natco Pharma USA LLC | TERIFLUNOMIDE | 14 mg/1 | 30 TABLET in 1 BOTTLE (69339-170-03) |
| 69339-170-09 | 69339-170 | HUMAN PRESCRIPTION DRUG | Teriflunomide | Teriflunomide | TABLET | ORAL | 20240102 | N/A | ANDA | ANDA209555 | Natco Pharma USA LLC | TERIFLUNOMIDE | 14 mg/1 | 90 TABLET in 1 BOTTLE (69339-170-09) |
| 69339-170-93 | 69339-170 | HUMAN PRESCRIPTION DRUG | Teriflunomide | Teriflunomide | TABLET | ORAL | 20230617 | N/A | ANDA | ANDA209555 | Natco Pharma USA LLC | TERIFLUNOMIDE | 14 mg/1 | 2 BLISTER PACK in 1 CARTON (69339-170-93) / 30 TABLET in 1 BLISTER PACK |